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Factors associated with the prevalence of arteriovenous fistulas Vascular access procedures and their subsequent com-
in hemodialysis patients in the HEMO Study. plications represent major causes of morbidity, hospital-
Background. Arteriovenous (AV) fistulas are the vascular ization, and cost for chronic hemodialysis patients [1–4].access of choice for hemodialysis patients, but only about 20%
Over 20% of hospitalizations in hemodialysis patientsof hemodialysis patients in the United States dialyze with fistu-
in the United States are access related, and the annuallas. There is little information known about the factors associ-
ated with this low prevalence of fistulas. cost of access morbidity has been estimated at close to
Methods. Multiple logistic regression analysis was used to $1 billion [4]. Polytetrafluoroethylene (PTFE) dialysis
evaluate the independent contribution of factors associated
grafts have decreased longevity as compared with nativewith AV fistula use among patients enrolled in the HEMO
arteriovenous (AV) fistulas [5–8] and are more prone toStudy. The analysis was conducted in 1824 patients with fistulas
or grafts at 45 dialysis units (15 clinical centers). recurrent stenosis, thrombosis, and infection [9]. Recog-
Results. Thirty-four percent of the patients had fistulas. The nizing the superiority of fistulas over grafts, the recently
prevalence of fistulas varied markedly from 4 to 77% among published National Kidney Foundation Dialysis Out-the individual dialysis units (P , 0.001). Multiple regression
comes Quality Initiative (DOQI) guidelines on vascularanalysis revealed five demographic and clinical factors that
access [10] recommend an aggressive approach to thewere each independently associated with a lower likelihood of
having a fistula, even after adjustment for dialysis unit. Specifi- creation of fistulas, with AV grafts being reserved for
cally, the prevalence of fistulas was lower in females than males patients whose vascular anatomy does not permit con-
[adjusted odds ratio (AOR) 0.37, 95% CI, 0.28 to 0.48], lower in
struction of a native AV fistula. Notwithstanding thesepatients with peripheral vascular disease than in those without
national recommendations, only about 20% of hemodial-(AOR 0.55, 95% CI, 0.38 to 0.79), lower in blacks than in
non-blacks (AOR 0.64, 95% CI, 0.46 to 0.89), lower in obese ysis patients in the United States have an AV fistula
patients (AOR per 5 kg/m2 body mass index, 0.76, 95% CI, as their vascular access [11]. In fact, the rate of fistula
0.65 to 0.87), and lower in older patients (AOR per 10 years, placement in new hemodialysis patients actually de-0.85, 95% CI, 0.78 to 0.94). The differences in the prevalence
creased between 1986 and 1990 [12].of fistulas among the dialysis units remained statistically sig-
There is little published information regarding the pa-nificant (P , 0.001) after adjustment for these demographic
and clinical factors. Finally, there were substantial variations tient characteristics that determine whether hemodialy-
in the prevalence of fistulas even among dialysis units in a sis patients receive an AV fistula rather than a graft.
single metropolitan area.
Female gender, older age, diabetes mellitus, and periph-Conclusions. Future efforts to increase the prevalence of
eral vascular disease have each been associated with afistulas in hemodialysis patients should be directed at both
hemodialysis units and patient subpopulations with a low fistula lower frequency of AV fistulas [6, 7, 12–14]. Moreover,
prevalence. geographic region has been identified as a major determi-
nant of fistula incidence within the United States, even
after adjustment for multiple demographic and clinicalKey words: angioaccess, age, race, diabetes, gender, vascular access,
chronic renal failure. factors [12]. Specifically, the incidence of fistulas among
new hemodialysis patients is highest in New EnglandReceived for publication November 11, 1999
and lowest in the Southeast.and in revised form May 24, 2000
Accepted for publication May 26, 2000 The HEMO Study is an ongoing large, prospective,
randomized clinical trial evaluating the effects of Kt/VÓ 2000 by the International Society of Nephrology
2178
HEMO Study Group: Prevalence of AV fistulas 2179
and dialyzer flux on patient mortality and morbidity [15]. if their severity score was $2 (this decision was made
prior to the statistical analysis). The ICED scores wereAs of April 1999, over 2000 hemodialysis patients have
been enrolled from 15 clinical centers (66 dialysis units) determined by the study coordinators under the supervi-
sion of the principal investigators. The study coordina-with a wide geographic distribution. The information
collected about these patients includes the type of vascu- tors were trained in the coding of the ICED prior to the
start of the study and annually during the study.lar access used for their dialysis. The purpose of the
present study was to evaluate the demographic and clini-
Statistical analysiscal factors that are associated with the type of vascular
access (AV fistula vs. graft) among the patients enrolled During a four-year period from March 1995 to April
1999, a total of 2149 patients were enrolled into thein the HEMO Study.
HEMO Study. The 150 patients using dialysis catheters
and patients in dialysis units enrolling fewer than 15
METHODS
subjects were excluded from further analysis. Thus, all
Patient population statistical analyses were restricted to the 1824 patients
dialyzing with either a fistula or graft in the 45 dialysisHemodialysis patients were recruited into the HEMO
Study from 66 hemodialysis units associated with 15 uni- units having at least 15 study patients. In addition, analy-
ses involving comorbidity had to be restricted to theversity-affiliated clinical centers. The major inclusion cri-
teria for patient recruitment included ages 18 to 80 and subset of patients in whom the ICED scores were ob-
tained (N 5 1371). Moreover, many patients declinedmaintenance hemodialysis for at least three months. The
major exclusion criteria included severe comorbid condi- to discuss their income, so that particular analysis was
restricted to those patients who provided this informa-tions associated with life expectancy of less than one year
(class IV congestive heart failure, chronic pulmonary tion (N 5 1402).
To assess whether clinical centers were associated withdisease requiring home oxygen, cirrhosis with encepha-
lopathy or coagulopathy, metastatic cancer, or AIDS), variations in the prevalence of fistulas that could not be
patients scheduled for a living-related kidney transplant, explained by the other demographic and clinical factors,
large residual renal function (urea clearance .1.5 mL/ we tested the significance of the clinical center as a single
min per 35 L of urea volume), and inability or unwilling- categorical variable (with 14 degrees of freedom to ac-
ness to follow the study protocol. Patients enrolled into count for possible differences among the 15 centers) in
the baseline (pre-randomization) phase of the HEMO a joint multiple logistic regression that also included the
Study served as the population for the current analysis. other demographic and clinical variables. A similar anal-
ysis was performed to determine whether the dialysis
Data collection unit was independently associated with the prevalence of
At the time of initial patient enrollment into the study fistulas. Separate univariate logistic regression analyses
extensive demographic and clinical information was col- were used to relate the odds of fistula to each of the
lected; it included age, sex, race, body mass index (BMI), identified associated variables in Table 1. These logistic
presence of diabetes mellitus, socioeconomic status (edu- regressions for the individually associated variables were
cation and income), as well as the type of vascular access then repeated controlling for dialysis unit. (In all cases,
that was being used for each patient (AV fistula, AV the same number of patients was used to calculate the
graft, or temporary dialysis catheter). The type of vascu- crude and adjusted analyses.) Stepwise logistic regres-
lar access was ascertained by the study coordinator at sion was used to identify a set of jointly significant vari-
each clinical center by direct inspection and/or review of ables associated with lower fistula use. The dialysis unit
the operative record. Approximately 70% of the baseline was treated as a single categorical factor in the stepwise
patients were randomized into the full-scale study. Addi- logistic regression. Among patients using fistulas, further
tional information was collected in this subset of patients logistic regression analyses were used to relate the odds
regarding comorbid illness (including coronary artery of upper arm placement to the respective associated vari-
disease, congestive heart failure, peripheral vascular dis- ables, while controlling for dialysis unit.
ease, and hypertension). An Index of Coexisting Disease
(ICED) was developed to score the severity of the co-
RESULTSmorbid conditions. The severity of each disease (coro-
The demographic and clinical characteristics of thenary artery disease, congestive heart failure, hyperten-
patient population are summarized in Table 1. The gen-sion, and peripheral vascular disease) was scored as 0 if
der distribution and the frequency of diabetes mellitusit was absent, 1 if it was asymptomatic or mildly symp-
in this study population were similar to those in thetomatic, 2 if it was moderately symptomatic, and 3 if it
prevalent U.S. hemodialysis population, whereas thewas severely symptomatic. For the purpose of the current
analysis, patients were classified as having a given disease proportion of HEMO Study patients with ages $65 years
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Table 1. Baseline patient characteristics dialysis was not associated with fistula prevalence. None
of the associations of comorbid conditions with fistulaVariables Values N %
prevalence was changed when the analysis was repeatedGender Female 937 51.4
Male 887 48.6 for all patients with a given comorbid condition, rather
Agea ,65 years 1180 64.7 than just those with a severity score $2. Stepwise logistic
$65 years 644 35.3
regression analysis identified six factors that were inde-Race Non-black 650 35.6
Black 1174 64.4 pendently associated with the prevalence of AV fistulas:
BMI ,27 kg/m2 1212 66.4 dialysis unit, female gender, obesity, peripheral vascular
$27 kg/m2 612 33.6
disease, age $65 years, and black race (Table 3). TheCADb No 845 61.6
Yes 526 38.4 discrepancy between fistula prevalence in blacks and
CHF b No 1224 89.3 whites occurred in both dialysis units with a high overall
Yes 147 10.7
proportion of fistulas, as well as in units with a low overallDiabetes No 1029 56.4
Yes 795 43.6 proportion of fistulas. Moreover, a lower prevalence of
Hypertensionb No 314 22.9 fistulas in black subjects was observed in both hemodialy-
Yes 1057 77.1
sis units with a high or low proportion of black subjects.PVDb No 1138 83.0
Yes 233 17.0 The clinical center was strongly associated (P , 0.001)
Smoker No 1066 58.4 with fistula prevalence even after adjustment for all other
Yes 758 41.6
demographic and clinical characteristics. The prevalenceIncomeb $$7500 per year 724 51.6
,$7500 per year 678 48.4 of fistulas varied substantially from 12 to 61% among
Education #HS 1249 68.5 the 15 clinical centers participating in the study. The preva-
.HS 575 31.5
lence of fistulas exceeded 40% in six centers, ranged be-ESRD duration ,1 year 484 26.5
1–5 years 899 49.3 tween 20 and 40% in six centers, and was less than 20%
.5 years 441 24.2 in three centers. The mean prevalence of fistulas was
Abbreviations are: CAD, coronary artery disease; PVD, peripheral vascular 45.3% at the four clinical centers in the Northeast, as
disease; CHF, congestive heart failure; BMI, body mass index (kg/m2); HS, high
compared with a mean prevalence of 30.6% in the fiveschool.
a Mean age, 57 6 14 years clinical centers in the Southeast. Not only did the fistula
b Information regarding comorbid conditions and income was not available
prevalence vary widely by geographic location, it alsofor some baseline patients who were not randomized into the full-scale study.
varied considerably even among hemodialysis units in
a single metropolitan region associated with individual
clinical centers (Fig. 1). Thus, for example, among the
were somewhat lower than for the general dialysis popu- five hemodialysis units associated with Clinical Center
lation (35 vs. 43%). The proportion of black patients in 11, the proportion of study patients with a fistula was
the HEMO Study was higher than in the general dialysis 28.6, 43.8, 50.0, 58.8, and 76.7%, respectively.
population (64 vs. 39%) [16], reflecting the preponder- The likelihood that a fistula was in the upper arm
ance of black patients among the clinical centers partici- versus the forearm was also examined, after restricting
pating in the HEMO Study. The patients enrolled in the the analysis to those dialysis units that had patients with
HEMO Study had substantial comorbidity, as summa- upper arm fistulas. Overall, 34% of all fistulas were in
rized in Table 1. the upper arm, and 66% were in the forearm. Controlling
Thirty-four percent of the study patients were dialyz- for dialysis unit, the adjusted odds ratio for having an
ing with a fistula, and 66% with a graft. The prevalence upper arm versus a forearm fistula was greater in female
of fistulas was strongly associated with both the clinical patients and patients with congestive heart failure (Table
center (P , 0.001) and with the dialysis unit (P , 0.001). 4). Specifically, the proportion of fistulas in the upper
The variation in fistula prevalence among the dialysis arm was 42.9% in women versus 30.1% in men. The
units remained statistically significant after controlling proportion of fistulas in the upper arm was 47.2% in
for clinical center (P 5 0.002), indicating that there was patients with congestive heart failure versus 32.6% in
significant variation in fistula prevalence among the dial- patients without heart failure. In contrast, patient age,
ysis units associated with the same clinical centers. Uni- race, diabetes mellitus, coronary artery disease, tobacco
variate analysis revealed a significantly lower prevalence use, peripheral vascular disease, hypertension, obesity,
of AV fistulas associated with female gender, age $65 income, education, and duration of dialysis did not corre-
years, black race, diabetes mellitus, obesity (BMI $27 late with the likelihood of having a fistula in the upper
kg/m2), peripheral vascular disease, coronary artery dis- arm rather than the forearm. On stepwise regression
ease, and annual income ,$7500 (Table 2). Each of these analysis, three factors were independently predictive of
associations persisted after adjustment for the dialysis a higher likelihood of an upper arm fistula: female gender
unit. In contrast, hypertension, congestive heart failure, (P 5 0.003), congestive heart failure (P 5 0.02), and
dialysis unit (P 5 0.005).smoking history, patient education, and the duration of
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Table 2. Univariate association of fistula use with other factors
Crude data Adjusted for HD unit
% Fistulas Odds ratio 95% CI Odds ratio 95% CI
Gender
Female 22.4 0.34b (0.27, 0.41) 0.35b (0.28, 0.44)
Male 46.3
Age
.65 years 27.8 0.64b (0.52, 0.79) 0.69a (0.55, 0.87)
,65 years 37.5
Race
Black 27.7 0.46b (0.38, 0.56) 0.57b (0.44, 0.75)
Non-black 45.5
BMI
.27 kg/m2 26.5 0.59b (0.48, 0.73) 0.56b (0.40, 0.71)
,27 kg/m2 37.9
CAD
Yes 30.4 0.73b (0.58, 0.92) 0.68a (0.52, 0.88)
No 37.5
CHF
Yes 33.3 0.93 (0.64, 1.33) 0.89 (0.59, 1.34)
No 35.0
Diabetes
Yes 25.4 0.50b (0.41, 0.61) 0.51a (0.41, 0.63)
No 40.7
Hypertension
Yes 34.4 0.93 (0.72, 1.22) 1.15 (0.85, 1.56)
No 36.0
PVD
Yes 29.2 0.74a (0.54, 0.99) 0.57a (0.40, 0.81)
No 35.9
Smoking
Yes 36.5 1.21 (0.99, 1.47) 1.22 (0.99, 1.52)
No 32.3
Income (per year)
,$7500 28.6 0.66b (0.53, 0.82) 0.76a (0.59, 0.98)
.$7500 37.9
Education




1–5 years 32.9 0.92 (0.73, 1.16) 0.89 (0.69, 1.15)
.5 years 35.4 1.02 (0.78, 1.34) 1.00 (0.74, 1.35)
Abbreviations are: OR, odds ratio of fistulas in the top vs. the bottom category; CAD, coronary artery disease; PVD, peripheral vascular disease; CHF, congestive
heart failure; BMI, body mass index; HS, high school.
a P , 0.05
b P , 0.001
c Statistical comparison for ESRD duration are relative to ESRD , 1 year group
DISCUSSION
The results of this analysis identify five demographic
and clinical factors, each of which was independently
associated with a lower likelihood of AV fistulas: female
gender, older age, obesity, peripheral vascular disease,
Table 3. Stepwise logistic regression relating fistula use to predictor and black race. These associations remained statistically
variables, controlling for dialysis unita
significant after adjustment for the hemodialysis unit.
Factor Adjusted OR 95% CI P value Two other multicenter studies have examined the factors
Female gender 0.37 (0.28, 0.48) ,0.001 influencing the type of vascular access in hemodialysis
PVD 0.55 (0.38, 0.79) ,0.001 patients in the United States [12, 17]. Because some of
Black race 0.64 (0.46, 0.89) 0.008
the conclusions differ among the three studies (Table 5),BMI per 5 kg/m2 0.76 (0.65, 0.87) ,0.001
Age per 10 years 0.85 (0.78, 0.94) ,0.001 it is important to recognize the methodologic differences
among them. Hirth et al analyzed two random samplesAbbreviations are: OR, odds ratio; PVD, peripheral vascular disease; and
BMI, body mass index. of hemodialysis patients drawn from the United Statesa Dialysis unit was also an independent factor predictive of fistula prevalence
(P , 0.001) Renal Data System (USRDS) [12]. Goodkin et al ana-
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Fig. 1. Frequency of fistula use among the hemodialysis units in the HEMO Study. The dialysis units are sorted with the clinical centers with
which they are affiliated. Hemodialysis units enrolling fewer than 15 patients have been excluded.
Table 4. Association of upper arm placement with other factors for in the prevalent hemodialysis population. Because the
patients with fistulas, controlling for dialysis unita
HEMO Study is a clinical trial, we did not attempt to
Factor Odds ratio 95% CI P value recruit a representative random sample of prevalent pa-
Hypertension 0.89 (0.53, 1.51) 0.67 tients. To the extent that the selection criteria excluded
BMI $27 kg/m2 0.94 (0.60, 1.44) 0.76 several types of patients, the conclusions from the pres-
Diabetes 0.97 (0.64, 1.46) 0.89
ent study may not be generalizable to all hemodialysisPVD 1.04 (0.53, 1.99) 0.91
CAD 1.11 (0.69, 1.78) 0.68 patients. Moreover, the percentage of fistulas in the pres-
Black race 1.13 (0.70, 1.82) 0.62 ent study (34%) was higher than the percentage of fistu-Education .HS 1.18 (0.78, 1.80) 0.44
las among all hemodialysis patients with permanent vas-Smoking 1.25 (0.86, 1.85) 0.25
Age $65 years 1.29 (0.83, 1.99) 0.25 cular accesses (,25%).
Duration ESRDa The USRDS study classified patients as having an AV.5 years 1.29 (0.75, 2.23) 0.36
fistula or graft, without requiring that the vascular access1–5 years 1.43 (0.89, 2.34) 0.15
Income #$7500/year 1.48 (0.90, 2.41) 0.11 was actually being used for dialysis. Specifically, “Pa-
Female gender 1.81 (1.22, 2.70) 0.003
tients with both a fistula and a temporary dialysis cathe-CHF 2.36 (1.11, 5.04) 0.026
ter were classified as having a fistula . . . it was presumedThis analysis excludes 8 dialysis units for which there were no HEMO Study
patients with upper arm fistulas. Abbreviations are: CAD, coronary artery dis- that the venous catheter was being used as a temporary
ease; PVD, peripheral vascular disease; CHF, congestive heart failure; BMI, access until the graft or fistula matured” [12]. Therebody mass index.
a Statistical comparison is relative to patients whose ESRD duration is ,1 year is no indication of what proportion of fistulas actually
matured sufficiently to be used for dialysis. However,
other studies have reported that 24% to 53% of fistulas
constructed fail to develop adequately to be used forlyzed the vascular access used in a random sample of
dialysis [8, 18, 19]. Moreover, the likelihood of primaryhemodialysis patients enrolled in the Dialysis Outcomes
fistula adequacy varies considerably among certain pa-and Practice Patterns Study (DOPPS) [17]. Both studies
tient subsets, being lower in older patients, diabetics,reported the vascular access of incident patients (within
and obese patients [19]. In the DOPPS Study, only one30 to 45 days of their first dialysis treatment). In contrast,
the current study examined the type of vascular access third of the incident patients had a permanent vascular
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Table 5. Association of fistula frequency with clinical factors: A comparison of published studies
HEMO Study USRDS [12] DOPPS [17] Others




Type of patient Prevalent Incident Incident Incident
Factor associated with lower
fistula frequency?
Female gender Yes Yes Yes Yes [6, 7, 13, 14]
Older age Yes Yes Yes Yes [14]
PVD Yes Yes No Yes [7]
Diabetes No Yes No No [14]
Obesity Yes No Yes N/A
Black race Yes No No N/A
Low income No Yes N/A N/A
Low education No Yes No N/A
Geographic location Yes Yes N/A N/A
HD unit preference N/A N/A Yes N/A
Abbreviations are: USRDS, United States Renal Data System; DOPPS, Dialysis Outcomes and Practice Patterns Study.
access (fistula or graft) at 45 days after initiation of hemo- rate. The USRDS study found no significant association,
but the determination of obesity was less precise (a sub-dialysis. Presumably, many of the incident patients with
temporary dialysis catheters received a permanent vascu- jective impression recorded in the medical record, rather
than an objective measurement). Because of the selec-lar access at a later date. This makes it difficult to extrap-
olate from factors influencing fistula frequency in the tion criteria for the HEMO Study, the effect of BMI on
fistula prevalence may have actually been underesti-incident population to factors predictive of fistulas in the
prevalent dialysis population. The present study evalu- mated. To qualify for randomization, the patients had
to achieve an equilibrated Kt/V of 1.45 (single-pool Kt/Vated the type of vascular access in use for dialysis in a
large, nonrandom, prevalent hemodialysis population. approximately 1.65) [15]. Among the 79 morbidly obese
patients (BMI $36 kg/m2), only 21.5% had a fistula.Notwithstanding these important methodologic differ-
ences, all three multicenter studies found a lower fre- The frequency of fistulas was lower in black subjects
(Table 2), and this difference persisted after adjustmentquency of fistulas among women and older patients. Sim-
ilar observations have been reported from a number of for multiple demographic and clinical factors, including
educational level, income, and dialysis unit (Table 3).single center studies [6, 7, 13, 14]. Peripheral vascular
disease was found to be a significantly associated with a Moreover, this association was observed in both dialysis
units with a high or low proportion of black subjects. Inlower fistula rate in the present study and in the USRDS
Study. The association was of marginal statistical signifi- contrast to the findings in the current study, black race
was not significantly associated with fistula frequencycance (P 5 0.09) in the DOPPS study, but was based on
analysis of a smaller number of incident patients with a among incident hemodialysis patients in the USRDS or
DOPPS Study. The explanation for the lower prevalencepermanent vascular access (N 5 298). Moreover, one
single-center study also has observed a lower frequency of fistulas in black hemodialysis patients in the current
study is not evident; it may be related to racial discrimina-of fistulas in patients with peripheral vascular disease
[7]. There was a lower frequency of fistulas among dia- tion or differences in the vasculature between blacks and
whites.betics as compared with nondiabetics in the USRDS
Study, but not in the DOPPS study or the current investi- Low income was associated with a lower frequency
of fistulas on univariate analysis in the present study.gation. Univariate analysis showed a strong association
between diabetes mellitus and a low prevalence of fistu- However, it was not independently associated with a
low fistula prevalence on multiple regression analysis.las in the current study (Table 2). However, on multiple
regression analysis (Table 3), diabetes mellitus dropped Income was lower in blacks than nonblacks and lower
in females than males; inclusion of race and gender inout as an independent predictor of fistula prevalence
(P 5 0.10). The knocking out of diabetes as an indepen- the multivariate analysis caused income to drop out as
an independent factor associated with fistula prevalence.dent factor was not due to a single factor, but rather due
to the cumulative effect of age, gender, BMI, race, and In contrast, the USRDS Study found low income to be
independently associated with fistula incidence. In theperipheral vascular disease.
Both the present study and the DOPPS Study found HEMO Study, income is assessed directly with a patient
questionnaire, whereas Hirth et al assessed income indi-an association between increased BMI and lower fistula
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rectly by matching the patient’s ZIP code, with ZIP codes lence of fistulas, as well as on patient subpopulations
with a low prevalence of fistulas. A number of individualassociated with .20% poverty levels [12]. The difference
in the methodology for determining income between dialysis centers have achieved a substantial increase in
the frequency of patients with fistulas by increasing theirthe two studies may account for the differences in their
conclusions. awareness of this issue and implementing a concerted
effort to improve outcomes. Three specific approachesFor patients with AV fistulas, the factors that were
associated with a higher likelihood of having it in the that have been used included a special focus on increas-
ing fistula placement in female patients [20], preferentialupper arm were examined (Table 4). Only female gender
and presence of heart failure were associated with this construction of fistulas in the upper arm rather than the
forearm [21], and preoperative venous mapping withfinding. A recent study reported that forearm fistulas in
female patients had only a 7% likelihood of maturing increased construction of transposition venous fistulas
[22, 23].adequately to be used for dialysis, whereas those in the
upper arm had a substantially higher probability (56%)
Reprint requests to Michael Allon, M.D., Division of Nephrology,
of achieving adequacy [19]. Recognition of the poor like- University of Alabama at Birmingham, 1900 University Boulevard,
South, THT 647, Birmingham, Alabama 35294, USA.lihood of maturation of forearm fistulas in women may
E-mail: mallon@nrtc.dom.uab.edulead vascular surgeons to attempt more fistulas in the
upper arm in female dialysis patients.
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